Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.
about
Multiple pathways for Plasmodium ookinete invasion of the mosquito midgutStrategies & recent development of transmission-blocking vaccines against Plasmodium falciparumVaccination against Lyme disease: past, present, and futureDifferential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion.Quantitative analysis of Plasmodium ookinete motion in three dimensions suggests a critical role for cell shape in the biomechanics of malaria parasite gliding motility.Comparative susceptibility of different biological forms of Anopheles stephensi to Plasmodium berghei ANKA strain.Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention.Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.Leishmania development in sand flies: parasite-vector interactions overview.A bioinformatics approach for integrated transcriptomic and proteomic comparative analyses of model and non-sequenced anopheline vectors of human malaria parasites.Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.Low density lipopolyprotein inhibits flavivirus acquisition in Aedes aegypti.Metazoan Parasite Vaccines: Present Status and Future Prospects.
P2860
Q27973868-EAABFA1C-9DF9-4A96-A330-79159C174717Q28072195-9770ACF0-69F0-448E-B740-E9735EA0D7A8Q34327726-8A184459-AF64-4E7A-BEF6-D90A8E9F3DF1Q34642131-F201C195-00E5-4FED-AE50-0D0EB754861BQ34865705-FB751AF8-8B04-4666-AFB5-CC3A23F4309AQ35005612-924456C0-28DA-4098-9BCC-71333E767091Q35097106-3AD32F29-71BA-4EAB-B3CE-9D77BB1C43DAQ35718341-0DC3DC33-C509-4BCA-ABF2-E112B6CE6FF3Q36499194-60231D22-E8E7-4637-B7BE-580AB852D9DCQ36508101-26BA7EDA-5E68-4E8D-82D9-4A48FD6AC938Q36889732-2EB94995-1833-4551-9411-20E2700CD359Q36998403-4B49D549-B302-487B-9C36-9286DB846C7DQ37546481-F69B999D-8CD3-4F8B-8F61-F92EE17C6111Q38157698-D999A691-9986-430E-995E-E9D69573FC93Q55024731-3B8B1A07-6F7C-4C5C-8FB1-829D7561BADC
P2860
Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression, immunogenicity, hi ...... -blocking recombinant vaccine.
@ast
Expression, immunogenicity, hi ...... -blocking recombinant vaccine.
@en
type
label
Expression, immunogenicity, hi ...... -blocking recombinant vaccine.
@ast
Expression, immunogenicity, hi ...... -blocking recombinant vaccine.
@en
prefLabel
Expression, immunogenicity, hi ...... -blocking recombinant vaccine.
@ast
Expression, immunogenicity, hi ...... -blocking recombinant vaccine.
@en
P2093
P2860
P50
P356
P1476
Expression, immunogenicity, hi ...... n-blocking recombinant vaccine
@en
P2093
A McMillan
A R Jariwala
D G Scorpio
D K Mathias
J L Plieskatt
J M Bethony
J S Armistead
P2860
P304
P356
10.1128/IAI.06212-11
P407
P577
2012-02-06T00:00:00Z